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Purpose: We describe the epidemiological and clinical char-
acteristics and the efficacy of a delayed initiation to therapy 
in an oropharyngeal tularemia outbreak in Duzce, Turkey. 
Materials and Methods: Between March and June 2000, 22 
patients with tularemia were diagnosed by microagglutination 
tests. Results: Oropharyngeal and ulceroglandular forms of the 
disease were discovered. Most of the cases were oropharyngeal (19 
cases). The most common symptoms were sore throat (95.4%) 
and fever (90.9%). Lymphadenopathy (95.4%) and pharyngeal 
hyperemia (81.8%) were usually observed signs. The lymphad-
enopathies were localized especially in the left cervical region 
(66.7%), a finding that has not been previously reported in the 
literature. The time between the onset of the symptoms and 
diagnosis was 40.7 ± 22.8 (10 - 90) days. The patients were 
treated with streptomycin plus doxycycline and ciprofloxacin. 
The patients' recoveries took up to 120 days. Conclusion: This 
report describes the first outbreak of tularemia in northwest 
Turkey. Tularemia may occur in any region where appropriate 
epidemiological conditions are found and should be kept in 
mind for differential diagnosis in oropharyngeal symptoms. 
Late initiation of therapy may delay complete recovery. In this 
outbreak, cervical lymph nodes predominantly localized on the 
1eft side were found, which had not been previously reported.
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INTRODUCTION
There are many reservoirs of F. tularencis in many 
parts of the world, including ticks and rodents, 
which may be associated with unusual increases in 
population density of these animal hosts.
1-5 Depen-
ding on the mode of transmission, tularemia presents 
various clinical forms, such as ulceroglandular, 
glandular, oculoglandular, oropharyngeal, pneu-
monic, and typhoidal tularemia forms. As an intra-
cellular pathogen, F. tularensis, causes granuloma-
tosus and suppurative lesions especially in the af-
fected regional lymph nodes and various organs.
5-8 
Diagnosis of tularemia mainly depends on serolo-
gical tests such as microagglutination, enzyme 
immune assay (EIA), immunochromatography, and 
PCR.
4,9,10 Without antimicrobial treatment, tularemia 
can be acute and fulminant or protracted and 
debilitating. Streptomycin, gentamicin, tetracycline, 
and fluoroqinolone antibiotics are effective, and 
early initiation of these agents is important in the 
effective treatment.
5,8,11,12
Tularemia has been reported in different parts 
of Turkey since 1936.
13 The present paper reports 
the clinical characteristics of 22 patients who were 
diagnosed with tularemia between March and 
June 2000 from Duzce (north-western Turkey). 
The aim of the study was to draw attention to the 
fact that tularemia may be found where there are 
differential diagnosis of patients with oropharyn-
geal symptoms and lymphadenopathy. 
MATERIALS AND METHODS
A total of 22 patients were diagnosed with 
tularemia between March and June 2000, in the 
Department of Clinical Microbiology and Infec-
tious Diseases, Abant Izzet Baysal University 
School of Medicine (Duzce, Turkey). All patients 
came from two neighbouring villages that were Oropharyngeal Tularemia Outbreak in Turkey 51
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situated in a forest region of Duzce-Akcakoca, in 
north-western Turkey.
By using a clinical history protocol, the fol-
lowing data were collected for all patients: symp-
toms, physical signs, and results of laboratory 
tests. All patients with suspected tularemia were 
physically examined. Detailed information about 
their occupation, the site of infection, day of onset, 
insect bites, contact with animals, working in 
poultry houses, clinical symptoms, and so on was 
obtained using an applied questionnaire. The sani-
tary conditions the water sources of these villages 
were examined.
The microagglutination tests for the tularemia 
diagnosis were performed in Uludag University, 
School of Medicine. The diagnosis was considered 
positive when the patient had an F. tularensis 
microagglutination titer of ≥ 1 : 40 or when sero-
conversion was present.
10,13 Before the diagnosis 
of tularemia, 15 patients had been using beta- 
lactam antibiotics and four patients had been 
using gentamicin in addition to beta-lactams, 
which was prescribed by their local practitioner. 
After the confirmation of tularemia, tetracycline 
plus streptomycin was used for 15 patients, and 
one patient was administered ciprofloxacin and 
another streptomycin. Therapeutic failure was 
defined by the presence of one of the following 
findings: persistence or recurrence of fever, in-
crease in the size or appearance of new lympha-
denopathies, and persistence of the constitutional 
syndrome with the elevation of the levels of the 
proteins that are associated with the acute phase 
of infection.
6,14 Disappearance of all signs and 
symptoms except for stationary lymphadeno-
megaly was accepted as a cure.
Fisher's Chi-square test was used for statistical 
analysis.
RESULTS
A total of 22 patients (11 females, and 11 males) 
were diagnosed with tularemia. The mean age 
(Mean ± SD) of the patients was 34.9 ± 17.2 (11 - 
70) years. None of the patients had a previous 
clinical history of tularemia. Three patients (13.6%) 
had a clinical history or signs of tick bites. For 19 
patients (86.4%) the water sources were not suit-
able as drinking water. The most important epide-
miological finding was that poultry farm work 
was the most common livelihood in this region, 
and increased rodent activity around poultry 
houses and villages had been reported by residents 
during the previous year. Furthermore, people 
living in the two villages were using water that 
was not treated with any disinfection or chlorina-
tion procedures. The water springs were contami-
nated with rattus and other wild rodent excre-
ments. One rattus carcass was found in one of the 
village wells. The epidemiologic characteristics of 
the patients with tularemia are shown in Table 1.
The time between the onset of the symptoms 
and diagnosis was 40.7 ± 22.8 (10 - 90) days. The 
most frequent symptoms were sore throat (95.4%) 
and fever (90.9%). Lymphadenopathy (95.4%) and 
pharyngeal hyperemia (81.8%) were the most fre-
quent signs. The lymphadenopathies were lo-
calized in the cervical region, especially in the left 
cervical area (66.7%). Three patients had a clinical 
history of tick bites, ulcero-nodular lesions 0.5 cm 
in diameter on the left forearm, and cervical 
lymphadenopathy. The oropharyngeal form was 
the most frequent with 19 cases, and the Ulcero-
glandular form was observed in 3 cases. The 
symptoms and signs of the patients are presented 
in Table 2.
The results from the patients' laboratory tests 
were normal, except for an increase in the levels 
of tests in ESR: 56 ± 16 mm/hour and leukocy-
tosis in blood: 11, 8 × 10
9/L ± 2, 1 × 10
9/L were ob-
served. Serological diagnosis was put on the basis 
of the following findings; the antibody titer 
against  F. tularencis was found to be over 1/160 
in 10 and 1/80 in 6 patients' sera. A four-fold rise 
of the antibody titer was determined in 6 cases. 
Brucella agglutination tests and anti-EBV IgM 
antibody with EIA were found negative. 
The patients were treated with intramuscularly 
administered streptomycin at a dosage of either 
1g every 24 hours or 500 mg every 12 hours for 
10 - 14 days, plus doxycycline (100 mg orally every 
12 hours for 2 weeks) and ,  i n  t h e  c a s e  o f  o n e  
patient, with ciprofloxacin (500 mg iv every 12 
hours for 14 days). No treatment was used for the 
5 patients who had been treated before for dif-
ferential diagnosis. All of the patients recovered 
within 120 days. The antibiotics used for the treat Irfan Sencan, et al. 52
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Table 3. Treatment Characteristics of the Patients (n = 22)
Antibiotics Response to treatment (n) Days to recovery (Mean ± SD)
Streptomycin + Doxycycline (n = 15) 8 73.7 ± 28.8
Streptomycin (n = 1) 0 75
Ciprofloxacin (n = 1) 1 32
No treatment (n = 5) - 82.0 ± 21.7
Table 2. Symptoms and Signs in Patients (n = 22)
Symptoms  n % Signs   n %
Sore throat 21 95.4 Lymphadenopathy  21 95.4
Fever 20 90.9 Right cervical  3 14.3
Chills 14 63.6 Left cervical 14 66.7
Headache 13 59.1 Bilateral  4 19.0
Myalgia 10 45.5 Pharynx hyperemia  18 81.8
Cough  5 22.7 Cutaneous ulceration  11 50.0
Abdominal pain  1  4.5 Tonsillary abscess   1  4.5 
Pulmonary symptoms  1  4.5
Diarrhea  1  4.5
Table 1. Epidemiologic Characteristics of the Patients with Tularemia
Epidemiological characteristics  n  %
Contaminated drinking water  19 86.4
Working in poultry houses  14 63.6
Insect bites   3 13.6
Presence of tularemia in households   3 13.6
Occupation
 Farmer
 Child 
 Forest  worker
 Hunter
18
 2
 1
 1
81.8
 9.1
 4.5
 4.5
ment of tularemia, responses to treatments, and 
recovery times are shown in Table 3.
DISCUSSION
Tularemia is transmitted to humans through 
various modes, including the direct handling of 
infectious carcasses, ingestion of contaminated food 
or water, arthropod bites, or inhalation of infec-
tious dusts or aerosols. However, the principal 
port of entry is through the skin.
2,3,5  F. tularensis 
has been isolated in wells that contained dead 
rodents and carcasses.
4,5
No previous epidemic had been reported in this 
region of Turkey. Residents reported increased Oropharyngeal Tularemia Outbreak in Turkey 53
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rodent activity around poultry houses and vil-
lages the previous year. The increases in rodent 
activity were probably due to insufficient wasting 
of hen carcasses in poultry houses. The present 
outbreak was considered waterborne because the 
water springs of these villages were contaminated 
with rattus and other wild rodent excrements. 
Reintjes R et al.
5 reported that, in rural areas, 
farmers were the most affected in the Kosova 
outbreak, which occurred in March 2000. In addi-
tion, rodents were found to be responsible for 
contaminating water supplies and food storage. 
The increases in local rodent populations were 
related to food storage areas that had been left 
unprotected and crops that had been left unhar-
vested. 
In this outbreak, the principal form of tularemia 
was the oropharyngeal form (19 cases), and the 
probable port of entry of the organisms was the 
oropharyngeal route. Clinical signs and symptoms 
that support the oropharyngeal route theory are 
as follows: 21 patients had a sore throat, 18 had 
pharyngeal hyperemia, and 21 had cervical lym-
phadenopathy.
In the Southwest-central states of the US, 1,026 
cases were analyzed between 1981 - 1987. The most 
frequent symptoms were fever (96%), lympha-
denopathy (77%), and cutaneous ulcers (65%).
15 
Christenson B et al.
16 evaluated 344 tularemia 
patients in a northern part of central Sweden, and 
the most frequent symptoms there were fever 
(94%), lymphadenopathy (87%), chills (83%), mus-
cle pain (55%), and sore throat (22%). Helvacı et 
al.
17 reported 205 patients with tularemia in 
Turkey, and lymphadenopathy (85%) was found 
to be the most frequent sign. Reintjes R et al.
5 
reported several hundred cases with a clinical 
picture of fever, pharyngitis, and cervical lympha-
denitis, together with serologic confirmation. 
In the present outbreak, the oropharyngeal form 
was found to be very high (86.4%). In contrast to 
reports in the literature,
1 most of the cases reported 
from Turkey and Kosova were in the oropharyngeal 
form. The clinical form in two neighbouring 
countries may be related to a common biotype of 
F. tularencis and a similar port entry.
In Japan, Ohara et al.
18 had observed swelling 
of axillary, cubital, and brachial lymph nodes 
predominantly on the left side in 1,355 cases 
between the years 1924 - 1987, and the authors ex-
plained that this situation may be due to the fact 
that right-handed persons held the captured 
animal firmly with the left hand while cooking. In 
this outbreak, lymphadenopathies predominantly 
were localized in the cervical region, especially on 
the left side (66.7%). This situation may be related 
to the localization of oropharyngeal ulcers, but we 
can make no further comment about this. Oro-
pharyngeal tularemia may be easily confused with 
other diseases that affect the cervical lymph nodes, 
such as streptococcus angina, tuberculosis, infec-
tious mononucleosis, and lymphoma.
6 This may 
lead to late diagnosis and inadequate treatment, 
as it was the case with the present epidemic. The 
delay was due to the novelty of this illness to the 
region. Tularemia should be considered in differ-
ential diagnoses where cervical lymphadenopathy 
is involved. 
The recommended agents for the treatment of 
tularemia include aminoglycosides (streptomycin 
and gentamicin) and tetracyclines.
8,12 It was de-
monstrated that ten strains of F. tularensis had in 
vitro susceptibility to ciprofloxacin, norfloxacin, 
ofloxacin, and pefloxacin.
19 The fluoroquinolones 
were found to be an excellent alternative. When 
therapy is not initiated within a few days of ill-
ness, defervescence may be delayed, and suppura-
tion may progress in spite of effective treat-
ment.
1,19 In the present outbreak, ciprofloxacin 
was used for only one patient, and a good result 
was obtained with this drug. Fifteen of the patients 
used a treatment of streptomycin plus doxycyc-
line. No treatment was used for five patients who 
had been using various antibiotics, such as genta-
micin, and whose disease had a mild clinical 
course. There were no significant differences 
between the different treatment protocols. The 
therapeutic failure that was observed in 8 patients 
may be related to the delay in the initiation of 
antibiotic therapy and the presence of fluctuating 
lymphadenopathies. The prognosis of the patients 
was good, and no patient died. 
What follows is a summary of findings: this is 
the first reported outbreak of oropharyngeal 
tularemia in our region. It appears that Tularemia 
was acquired through contact with water that was 
contaminated by rodents. An increase in the 
number of rodents may be related to the waste Irfan Sencan, et al. 54
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from poultry houses. The Oropharyngeal form of 
the disease was the most frequent, as it was in 
other outbreaks reported from Turkey and Kosova. 
In this outbreak, one of the interesting findings 
that had not been previously reported was the 
repeated cases of cervical lymphadenopathies on 
the left.
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